Novozymes A-S (B) Aktie
55,74
EUR
+1,18
EUR
+2,16
%
54,80
EUR
+0,40
EUR
+0,74
%
Werbung
Novozymes A-S (B) Aktie Analyse
17.10.12 | Novozymes A-S (B) hold | Deutsche Bank AG | |
03.09.12 | Novozymes A-S (B) buy | ING | |
28.08.12 | Novozymes A-S (B) overweight | Morgan Stanley | |
09.08.12 | Novozymes A-S (B) overweight | Morgan Stanley | |
19.06.12 | Novozymes A-S (B) overweight | Morgan Stanley | |
17.11.11 | Novozymes A-S (B) overweight | Morgan Stanley | |
15.10.10 | Novozymes A-S (B) hold | Vontobel Research | |
13.08.10 | Novozymes A-S (B) hold | Vontobel Research | |
Werbung
|
|||
04.05.05 | Novozymes A-S (B) Sector Underperform | Vontobel |
Werbung
Werbung